Latest news

Insights

Top 10 Drug Discovery Platforms to Watch

Executive Summary Artificial intelligence is changing how pharmaceutical companies identify drug targets, design molecules, evaluate therapeutic candidates, and prioritize research...
Insights

Launch Excellence in the Digital Era

Executive Summary Launching a pharmaceutical product has become increasingly complex. Scientific innovation alone does not guarantee commercial success. Market access...
Insights

Top 10 Factors That Determine the Success of a Drug Candidate

Executive Summary A promising drug candidate must overcome multiple scientific, clinical, regulatory, manufacturing, and commercial challenges before becoming an approved...
Insights

Spatial Biology and Its Commercial Potential

Executive Summary Spatial biology is emerging as an important capability in pharmaceutical research and precision medicine. By examining the location...
Clinical

Neurocrine Plans Vykat Safety Study After Reports of Patient Deaths

Neurocrine Biosciences plans to conduct a new study in...
Commercial

Just two months after entering the clinic, Sanofi removes the STAT6 degrader from Nurix

Sanofi has decided to end work on a STAT6...
Insights

Top 10 Technologies Improving Patient Retention

Executive Summary Maintaining patient engagement throughout treatment is a growing priority for pharmaceutical companies and healthcare providers. Patients may discontinue...
Insights

Building AI-Ready Data Platforms in Life Sciences

Executive Summary Artificial intelligence is becoming central to pharmaceutical research, clinical development, manufacturing, and commercial operations. Yet many organizations struggle...
Clinical

Phase 3 psoriasis victory: China’s InventisBio provides competitive TYK2 data

Phase 3 Success and Primary Endpoint Achieved InventisBio's nomelcitinib met its primary endpoint in a phase 3 trial, providing proof...
Clinical

Teva Discontinues Phase 2 Emrusolmin Trial for Multiple System Atrophy

Teva Pharmaceuticals is discontinuing its Phase 2 clinical trial...
Insights

Top 10 Digital Capabilities Separating Industry Leaders

Executive Summary Digital maturity is becoming a competitive differentiator across...
Commercial

Astellas wagers $1.3 billion on Audax’s preclinical effort to end decades of IL-12 problems

Financial Terms and Partnership Scope Astellas has agreed to up to $285 million in upfront and option payments to get...
Technology

Vera Health Raises $28.5 Million to Expand Clinical AI Search Platform

Vera Health, a clinical artificial intelligence search engine, has secured $28.5 million in Series A funding to expand its...
Clinical

Novartis Reports Late-Stage Trial Setbacks for Del-Desiran and Pelacarsen

Novartis reported late-stage clinical trial failures for two experimental medicines in September, including del-desiran, which was being developed for...
Commercial

Life Sciences Voice In Collaboration With Future Pharma EU 2026

Future Pharma Europe returns on 20–21 October 2026 in...
Editorial Team -
Commercial

Novartis Leaves $800M Neuro Partnership, Leaving BioArctic High And Dry

The pharmaceutical industry has lost another potential neuroscience development...
Editorial Team -
Commercial

Roche’s Acquisition of Spark Falls Short as Another Therapy Exits Pipeline

Roche’s 2019 acquisition of Philadelphia-based gene therapy specialist Spark...
Commercial

Moberg Pharma joins hands with Allderma to market nail fungus product in Scandinavia

Moberg pharma joins hands with Allderma to enter the...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Vera Health Raises $28.5 Million to Expand Clinical AI Search Platform

Vera Health, a clinical artificial intelligence search engine, has secured $28.5 million in Series...
Editorial Team -

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Suki announced Tuesday the release of Suki Dictation, an artificial intelligence-powered dictation solution designed...
Editorial Team -

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Regulatory

Regulatory

GSK’s Hepatitis B Drug Gets FDA Green Light

GSK has secured U.S. approval for bepirovirsen, an antisense...
Editorial Team -
Insights

Launch Excellence in the Digital Era

Executive Summary Launching a pharmaceutical product has become increasingly complex....
Insights

Top 10 Factors That Determine the Success of a Drug Candidate

Executive Summary A promising drug candidate must overcome multiple scientific,...
Insights

Spatial Biology and Its Commercial Potential

Executive Summary Spatial biology is emerging as an important capability...
Commercial

Novartis Leaves $800M Neuro Partnership, Leaving BioArctic High And Dry

The pharmaceutical industry has lost another potential neuroscience development...

Research & Development

Market Access

Manufacturing

Edgewise Reports Phase 2 CIRRUS-HCM Results for EDG-7500 Ahead of Planned Phase 3 Development

Edgewise Therapeutics has reported top-line results from Part D...
Manufacturing

Genentech signs a $490 million breast cancer partnership and lays off 103 employees with gRED Rethink

The Roche subsidiary has just announced that the restructuring...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Top 10 Drug Discovery Platforms to Watch

Executive Summary Artificial intelligence is changing how pharmaceutical companies identify...
Editorial Team -
Insights

Top 10 Factors That Determine the Success of a Drug Candidate

Executive Summary A promising drug candidate must overcome multiple scientific,...
Editorial Team -